Abstract
Leukotrienes play a major role in the underlying pathophysiology of asthma. Leukotriene-receptor antagonists and direct leukotriene-synthesis inhibitors may be important new agents in maintenance therapy for asthma. Their role may also extend to attenuating exercise-induced and allergen-induced bronchospasm. This article reviews the effectiveness of available leukotriene modifiers in various clinical studies, reviews their adverse effects profile, and discusses their potential roles in the management of asthma.
| Original language | English (US) |
|---|---|
| Pages (from-to) | S1-6 |
| Journal | The Journal of the American Osteopathic Association |
| Volume | 99 |
| Issue number | 7 Suppl |
| DOIs | |
| State | Published - Jul 1999 |
All Science Journal Classification (ASJC) codes
- Complementary and alternative medicine